AI Tool detects prostate cancer more accurately than doctors, UCLA study
AI tool may spot prostate cancer with 84% accuracy, according to a UCLA research, outperforming doctors who had a 67% accuracy rate. Unfold AI, an AI program created by Avenda Health, visualizes the possibility of cancer by analyzing clinical data using an algorithm. Seven urologists and three radiologists tested this tool—which was just approved by the FDA—by looking for leftover cancer in 50 cases of removed tumors. After doing the same study again, the AI found a far greater «negative margin rate,» which indicates a smaller chance of cancer being left behind, as per the reports of Fox news.
Union Budget 2024 Live Updates
Enhanced treatment options with AI
Dr. Ali Kasraeian of Jacksonville manages prostate cancer with the aid of Unfold AI. Using patient data such as pathology and biopsy results, the AI generates a 3D map for estimating cancer. In order to maximize the chance of curing cancer and customize care, this thorough mapping helps identify whether a patient needs targeted therapy or more severe treatments. In order to reduce the necessity for full-gland removal and its related side effects, like incontinence and impotence, the study implies that AI could lead to more precise diagnoses and focused therapies.
As per the reports of Fox news, after a tumor was discovered on his prostate, Joshua Trachenberg, a UCLA professor and patient with prostate cancer, looked into non-surgical treatments for his illness. The UCLA team targeted and removed cancerous tissue while protecting the remaining portion of the gland using ultrasound guided by magnetic resonance imaging (MRI). Trachenberg was able to avoid radical prostatectomy and its related side effects due to Unfold AI's 3D mapping, which was
